ETOPOPHOS (E.R. Squibb & Sons, L.L.C.)
Welcome to the PulseAid listing for the ETOPOPHOS drug offered from E.R. Squibb & Sons, L.L.C.. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | E.R. Squibb & Sons, L.L.C. |
| NON-PROPRIETARY NAME: | etoposide phosphate |
| SUBSTANCE NAME: | ETOPOSIDE PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-06-01 |
| END MARKETING DATE: | 0000-00-00 |
ETOPOPHOS HUMAN PRESCRIPTION DRUG Details:
| Item Description | ETOPOPHOS from E.R. Squibb & Sons, L.L.C. |
| LABELER NAME: | E.R. Squibb & Sons, L.L.C. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2009-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0015-3404_313e8121-bbc5-4317-8e2e-c3a5b1a86996 |
| PRODUCT NDC: | 0015-3404 |
| APPLICATION NUMBER: | NDA020457 |
Other ETOPOSIDE PHOSPHATE Pharmaceutical Manufacturers / Labelers:
